Table 1.
Patients characteristics
| Variables | |
|---|---|
| Total number of patients (n) | 24 |
| Patient sex | |
| Men | 13 |
| Women | 11 |
| Age at time of diagnosis (years) | |
| Median | 55.5 |
| Range | 29-81 |
| Primary tumor entity: number of patients/total number of lesions per entity (n) | |
| Colorectal carcinoma | 5/7 |
| Cholangiocellular carcinoma | 4/7 |
| Renal cell carcinoma | 3/7 |
| Pancreatic ductal adenocarcinoma | 3/5 |
| Hepatocellular carcinoma | 2/4 |
| Ovarian cancer | 2/2 |
| Cancer of unknown primary | 2/5 |
| Malignant pheochromocytoma | 1/4 |
| Malign melanoma | 1/3 |
| Urothelial carcinoma | 1/3 |
| Distant metastasizing | |
| Synchronous | 9 |
| Metachronous | 15 |
| Number of lesions (n) | 47 |
| Maximum diameter (cm) | |
| Median | 2.2 |
| Range | 1.0-8.6 |
| Lesions per patient (n) | |
| Median | 2 |
| Range | 1-4 |
| Administered D100; range (Gy) | |
| Median | 14.9 |
| Range | 4.5-20.6 |
| Follow-up time (months) | |
| Median | 9.6 |
| Range | 2.9-39.0 |